By Ed Silverman // February 8th, 2013 // 10:35 am
In the wake of the fungal meningitis outbreak that was linked to a compounding pharmacy and has so far caused as many as 45 deaths, the FDA has nixed an experiment proposed several years ago by a different compounding pharmacy that hoped to use bar codes after its medicines were shipped as a way of identifying patient use. The idea, of course, is not the same as compounding specific drugs for individual patients with prescriptions ahead of time.
Continue reading here
No comments:
Post a Comment